Enzo Biochem, Inc. (ENZ)
Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since ENZ was founded in 1976, their strategic focus has been on the development of enabling technologies in the life sciences field.
Contrary to its name, biotechnology is not a single technology. Rather it is a group of technologies that share two (common) characteristics working with living cells and their molecules and having a wide range of practical uses that can improve our lives.
Biotechnology can be defined as “using organisms or their products for commercial purposes.” As such, (traditional) biotechnology has been practiced since the beginning of recorded history. (It has been used to bake bread, brew alcoholic beverages, and breed food crops or domestic animals. But recent developments in molecular biology have given biotechnology new meaning, new prominence, and new potential. It is (modern) biotechnology that has captured the attention of the public. Modern biotechnology can have a dramatic effect on the world economy and society.
Enzo Biochem Inc. recently announced that it has added four highly experienced executives at its Enzo Life Sciences subsidiary to focus on rapidly evolving new pharmaceutical and clinical applications.
The officers, all filling newly created positions, are Bruce Taillon, PhD, as head of global technology business development, John D’Errico, PhD, to lead the commercial merchandising operations, Kara Cannon, as head of global marketing and Paul Munger, PhD, to lead Global Manufacturing.
Over the past two years, Enzo has been engaged in enhancing the Life Sciences subsidiary’s operating performance through added capabilities, greater integration and a more focused product mix. These efforts are all aimed at significantly expanding Enzo’s presence and marketing beyond the traditional academic and research laboratory core to greater penetrate the pharmaceutical and clinical customer base with new and cutting edge platform technologies.
For more information about Enzo Biochem Inc. visit its website: http://www.enzo.com
Camden Property Trust (NYSE:CPT) announced that its third quarter 2011 earnings will be released after the close of market on Thursday, November 3, 2011. Management will host a conference call on the following day, Friday, November 4, 2011 at 11:00 a.m. Central Time
Camden Property Trust operates as a real estate investment trust (REIT) in the United States. It engages in the ownership, development, construction, and management of middle- to upper-market multifamily communities.
Baxter International Inc. (NYSE:BAX) continued to advance math and science education and reduce its environmental footprint through several recent initiatives. Baxter also supported the opening of a new education center in Chicago to prepare high schoolers for careers in health sciences and optimized product transport in Europe. The company was also recognized for the 10th year as Medical Products leader in the Dow Jones Sustainability Index.
Baxter’s commitment to sustainability spans more than three decades. The company is included in the Dow Jones Sustainability Index and has been recognized by Corporate Knights as one of the Global 100 Most Sustainable Corporations in the World and by Corporate Responsibility magazine as one of the 100 Best Corporate Citizens. Baxter also ranked first in the healthcare category of Newsweek’s annual Green Rankings since the list’s inception in 2009.
Cleantech Transit, Inc. (CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could benefit the Company’s manufacturing clients worldwide.
Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company’s ability to earn in 25% of the 500KW Merced Project.
The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.
The increased global production of biofuels such as ethanol has become a subject of controversy, as land formerly dedicated to the growing of food crops is repurposed to meet energy needs. Each year, more crops such as sugar, palm oil, corn and cassava are diverted for these purposes.
Biofuel production and use must coincide with reductions in the production and use of fossil fuels for these benefits to accrue. These benefits would be mitigated if biofuel emissions and resource demands augment, rather than displace, those of fossil fuels.
For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com
PartnerRe Ltd. (NYSE:PRE) announced that Andrew J. Turnbull has joined the Company in the newly-created position, Group Strategy and Business Development Officer. Mr. Turnbull will report to PartnerRe Chief Executive Officer Costas Miranthis. In this position, Mr. Turnbull will help guide the Company’s strategic planning and development, including evaluation of business opportunities.
PartnerRe Ltd., through its subsidiaries, provides reinsurance services worldwide. It offers reinsurance coverage to insurers for property damage or business interruption losses resulting from fires, catastrophes, and other perils covered in industrial and commercial property, and homeowners’ policies; and casualty reinsurance products, which include third party liability, employers’ liability, workers’ compensation, and personal accident coverage.
No comments:
Post a Comment